Unknown OBSERVATIONAL NCT04835207

Metabolic Profile as a Predictor of No-reflow in Diabetic Patients

Metabolic Profile as a Predictor of No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention ( PCI ) .

Sponsor: El Zahraa Gamal

Conditions Acute Myocardial Infarction (AMI)

Interventions 1- LDL-C (low-density lipoprotein cholesterol) and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S

Updated 4 times since 2021 Last updated: Apr 7, 2021 Started: Apr 30, 2021 Primary completion: Apr 30, 2022 Completion: Apr 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04835207, this observational or N/A phase trial focuses on Acute Myocardial Infarction (AMI) and remains ongoing. Sponsored by El Zahraa Gamal, it has been updated 4 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2023 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
May 2021 — May 2023 [monthly]

Not Yet Recruiting

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

El Zahraa Gamal

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.